PCR & Real-time PCR Molecular Diagnostics Market

1. Advantages over Alternative Virus Isolation Techniques to Drive Demand Over the past few decades, polymerase chain reaction (PCR) molecular diagnostics has gradually established itself as one of the most critical laboratory tools. Advancements in PCR & real-time PCR molecular diagnostics are largely driven by minor changes to enzymes and large-scale changes in a particular result. At present, considerable research and development activities are being carried out to improve the reliability and accuracy of PCR & real-time PCR molecular diagnostics– a factor that is expected to bolster the market growth during the forecast period. Report molecular-diagnostics-market.html Overview: https://www.transparencymarketresearch.com/pcr-realtime-pcr- The outbreak of the novel COVID-19 pandemic is expected to play an imperative role in accelerating the growth of the global PCR & real-time PCR molecular diagnostics market, as PCR & real-time diagnostics is highly critical to detect virus in individuals who exhibit no symptoms or signs of disease. In addition, the adoption of PCR & real- time PCR molecular diagnostics is on the rise for the identification and detection of Pseudomonas aeruginosa. This is likely to boost the overall prospects of the global PCR & real-time PCR molecular diagnostics market during the assessment period. The increasing collaborations between private scientific laboratories and research institutes is projected to build a solid foundation for the PCR & real-time PCR molecular diagnostics market. At the back of these factors, along with consistent advancements in technology and virus detection techniques, the global PCR & real-time PCR molecular diagnostics market is expected to surpass US$ 6.5 Bn mark by the end of 2030. Request https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=791 97 Sample: Strides Taken by Quantitative PCR & Real-time PCR Molecular Diagnostics to Aid Market Growth At present, the various techniques deployed across the molecular biology and medical diagnostics space are highly time-consuming and labor-intensive due to which, researchers and medical experts continue to focus on the discovery of time-efficient, reliable, and effective medical diagnostics. The PCR & real-time PCR molecular diagnostics has garnered considerable popularity over the past couple of decades, as

2. it enables multiplication of a target DNA molecule due to which, the diagnosis of a range of diseases with a higher accuracy was made possible. This factor is anticipated to drive the PCR & real-time PCR molecular diagnostics market during the assessment period. Researchers and stakeholders involved in the current PCR & real-time PCR molecular diagnostics market are of the opinion that quantitative PCR & real-time PCR molecular diagnostics is a highly robust and reliable medical diagnostics technique. Moreover, PCR & real-time PCR molecular diagnostics have a lower risk of cross-contamination, as it is predominantly carried out in automated thermal cyclers. Moreover, investments for PCR & real-time PCR molecular diagnostics have witnessed consistent growth over the past decade. Moreover, as per current observations, the trend is set to continue in the upcoming decade, due to the tremendous scope of PCR & real-time PCR molecular diagnostics in the near future. Enquiry https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=7 9197 Before Buying: The outbreak of the novel COVID-19 pandemic is expected to boost to the overall growth of the global PCR & real-time PCR molecular diagnostics market. Several established international organizations, including IAEA and Food and Agriculture Organization (FAO) are increasingly offering their support and expertise to various nations to facilitate the adoption of real-time reverse transcription- PCR & real-time PCR molecular diagnostics– one of the most reliable and accurate laboratory techniques used to track, detect, and assess the novel COVID-19 coronavirus strain. The demand for PCR & real-time PCR molecular diagnostics has witnessed noteworthy growth in 2020, as governments of various nations around the world are increasingly offering monetary and policy-driven support to players involved in the PCR & real- time PCR molecular diagnostics market. In comparison with the alternative virus isolation techniques, PCR & real-time PCR molecular diagnostics has a lower risk of cross-contamination and is notably faster. This is expected to drive the demand for PCR & real-time PCR molecular diagnostics during COVID-19. Analysts’ Viewpoint The global PCR & real-time PCR molecular diagnostics market is expected to expand at a moderate CAGR of ~4% during the forecast period. The market growth is primarily driven by factors such as advancements in technology, progress made by quantitative PCR & real-time PCR molecular diagnostics techniques, benefits over other virus isolation and detection techniques, and growing emphasis on improving the reliability of end-results of PCR molecular diagnostics. The demand for PCR & real-time PCR molecular diagnostics has witnessed tremendous growth in 2020, due to the onset of the

3. COVID-19 pandemic. Furthermore, as per current trends, the adoption is likely to gain momentum, as governments around the world continue to take drastic measures to curb the transmission of the COVID-19 virus. PCR & Real-time PCR Molecular Market: Overview According to Transparency Market Research’s latest research report on the global PCR & real-time PCR molecular market for the historical year (2018), base year (2019), and the forecast period (2020–2030), technological advancements and increase in burden of cancer & infectious diseases across the globe are projected to drive the global PCR & real-time PCR molecular market in the near future  According to the report, the global PCR & real-time PCR molecular market was valued over US$ 4.1 Bn in 2019. It is anticipated to expand at a CAGR of ~4% from 2020 to 2030.  Request https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79197 Brochure: Rise in Burden of Cancer & Infectious Diseases to Drive Global Market Rise in prevalence of cancer and infectious diseases is projected to drive the market during the forecast period. Hepatitis and HIV are major infectious diseases. According to the World Health Organization (WHO), as of October 2017, nearly 71 million people across the world were estimated to be suffering from hepatitis C infection. The organization also stated that 36.7 million people were affected with HIV, globally. According to the WHO, lung, breast, colorectal, prostate, skin, and stomach cancer are common types of cancers that are prevalent across the globe. According to the American Cancer Society, the most common cancers in the U.S. are breast cancer, lung cancer, prostate cancer, colorectal cancer, and melanoma. According to the Urology Care Foundation, about one in every seven men is diagnosed with prostate cancer in the U.S., and approximately, one in 35 men succumbs to the disease. In 2020, 191,000 men are likely to be diagnosed with prostate cancer.   Increase in Demand for Molecular Diagnostic Tools to Propel Global Market Expansion of the market is projected to be driven by technological advancement, regulatory approvals, and increase in adoption of molecular diagnostic tools in oncology and infectious diseases. Early detection plays a significant role in management of cancer. Molecular diagnostics offers a wide range of tools for accurate and reliable diagnosis of diseases. Additionally, PCR-based systems help enhance workflow to reduce the overall cost and eliminate the need for multiple systems 

4. PCR & Real-time PCR Molecular Market: Competition Landscape This report profiles major players operating in the global PCR & real-time PCR molecular market based on attributes such as company overview, financial overview, product portfolio, major brands, business strategies, and recent developments  The global PCR & real-time PCR molecular market is highly competitive with the presence of prominent players in the international market. Top players hold prominent share of the global PCR & real-time PCR molecular market.  Prominent players operating in the global PCR & real-time PCR molecular market include  oAbbott Laboratories oBio-Rad Laboratories, Inc. obioMérieux SA oDanaher Corporation oThermo Fisher Scientific, Inc. oBecton, Dickinson and Company oF. Hoffmann-La Roche Ltd oQIAGEN N.V. oHologic, Inc. oGRIFOLS oS.A. oGenomic Health oSeegene, Inc. About Transparency Market Research Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research company providing custom research and consulting services. TMR provides in-depth insights into factors governing demand in the market. It divulges opportunities across various segments based on Source, Application, Sales Channel, and End- Use that will favor growth in the market over the next 9 years. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research

5. techniques in developing distinctive data sets and research material for business reports. For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ Contact Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email:sales@transparencymarketresearch.com